KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Tax Provisions (2019 - 2026)

GoodRx Holdings' Tax Provisions history spans 7 years, with the latest figure at $8.8 million for Q4 2025.

  • On a quarterly basis, Tax Provisions rose 87.79% to $8.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.1 million, a 73.19% increase, with the full-year FY2025 number at $26.1 million, up 73.19% from a year prior.
  • Tax Provisions hit $8.8 million in Q4 2025 for GoodRx Holdings, up from $5.0 million in the prior quarter.
  • Over the last five years, Tax Provisions for GDRX hit a ceiling of $45.8 million in Q4 2021 and a floor of -$46.7 million in Q2 2023.
  • Historically, Tax Provisions has averaged $956950.0 across 5 years, with a median of $4.4 million in 2024.
  • The widest YoY moves for Tax Provisions: up 1189.69% in 2021, down 586.95% in 2021.
  • Tracing GDRX's Tax Provisions over 5 years: stood at $45.8 million in 2021, then crashed by 106.06% to -$2.8 million in 2022, then skyrocketed by 144.5% to $1.2 million in 2023, then surged by 278.36% to $4.7 million in 2024, then skyrocketed by 87.79% to $8.8 million in 2025.
  • Business Quant data shows Tax Provisions for GDRX at $8.8 million in Q4 2025, $5.0 million in Q3 2025, and $6.7 million in Q2 2025.